CD4+ T lymphocytes are believed to play a key role in the pathogenesis of human IBD, as evidenced by their influx into the inflamed mucosa, the effectiveness of depleting anti-CD4 antibody therapies [28], or the suppression of Crohn's disease symptoms observed in individuals with concomitant HIV infection [29]. The gene discussed is CD4; the disease is inflammatory bowel disease.